论文部分内容阅读
目的 观察微导管持续心包引流并白细胞介素 - 2心包内注射对恶性心包积液的疗效。方法 10例恶性心包积液患者行微导管持续引流后 ,心包内注射白细胞介素 - 2 2 0 0万 U。结果 10例中 9例完全缓解 ,1例部分缓解 ,平均生存期 14.9月。结论 持续微导管引流并白细胞介素 - 2心包内注射治疗是对恶性心包积液的有效方法 ,能改善患者的生活质量 ,延长晚期肿瘤病人的生存期。
Objective To observe the effect of continuous catheterization of pericardium and interleukin - 2 pericardial injection on malignant pericardial effusion in microcatheter. Methods Ten patients with malignant pericardial effusion underwent continuous percutaneous catheterization of the microcatheter and received pericardial injection of 20 million U of interleukin. Results Of the 10 cases, 9 cases were completely relieved and 1 case partially relieved. The average survival time was 14.9 months. Conclusion Continuous microcatheter drainage combined with IL - 2 pericardial injection is an effective method for malignant pericardial effusion, which can improve the quality of life of patients and prolong the survival of advanced cancer patients.